PennyProfits Alerts
About Us:
PennyProfits.com is an Internet based financial media service, which aggregates & distributes news and corporate developments within the micro-cap and penny stock markets. PennyProfits has a research database comprised of over 6,000 companies trading on the Pink Sheets® & OTCBB. We continue to expand our offerings through internal development, such as our Capsule Awareness Program (C.A.P.) and through external partnerships.
MARKET RECAP
3/26/10 - Market Micro Recap For Week Of 3/22/10
The OTC companies tracked by PennyProfits moved down this past week, pushing the average stock price 0.1323% to the downside. Fully updated companies now numbers 4412, with the full database hovering at 6,514. See below for several headlines, which moved stocks.
Innovative Beverage Group Holdings, Inc. (IBGH) announced a new partnership with Trent Beverage Company, to bring drank™, the world's first extreme relaxation beverage to Southern California, marking another exciting distribution deal in the Golden State. Trent Beverage Co. provides distributors in four Southern California counties with unique name brand products such as Volvic Water®, Xyience™, Gleukos™, Xing Tea, Jana™ and Hint®. The distribution will encompass Kern, San Bernardino, Riverside and Imperial counties and help bring drank to many eager consumers.
EcoBlu Products, Inc. (ECOB) announced that it has shipped over 6,500 board feet of BLUWOOD™ coated lumber to Center Termite and Pest Control of Southern California for termite remediation work. Center Termite exclusively uses BLUWOOD™ coated lumber in all of its work because of its ability to protect against termites, mold, rot, and fire.
Cord Blood America, Inc. (CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.
WindPower Innovations, Inc. (WPNV) announced that the contract to acquire XH Industries, Inc. with fully equipped and operating facilities in California and Washington has now been completed without contingencies and the closing date is immediate. The purchase price is restricted common stock and some cash to be paid out over the next year. XH Industries, Inc. is presently repairing wind turbine gear boxes, and other components and has been in the repair business since 1985. In addition to the two facilities to repair wind turbine components, XH Industries has ownership of 50 older wind turbines that have been taken out of service. These complete wind turbine systems will be reworked and sold with complete warranties. This is a facet of the clean energy business that WindPower Innovations was originally formed to enter and presents the opportunity to be a complete service facility for the industry immediately.
QuoteMedia, Inc. (QMCI), a leading provider of market data, corporate research information and financial applications, announced an enterprise agreement with Gmarkets Inc., a financial information company specializing in the delivery of real-time global fixed income and capital markets data. Effective immediately, Gmarkets will incorporate Quotestream Professional into its existing product line, which Gmarkets currently provides to both sell-side and buy-side market participants, with a substantial presence in most financial institutions in Canada and a growing footprint in the U.S.
ChromoCure, Inc. (KKUR) announced an expansion of its Cancer Research initiatives with Live Animal Therapeutics Research collaboration with selected University Cancer Research Programs. This Collaborative Research Initiative will be a strategic expansion of the Company's "Project Boveri: Find the Cure," adding the ability to monitor hourly chromosome aneuploidy progression. The company's technology and related research opens the way for non-invasive and non-toxic solutions to cancer therapeutics and disease eradication. The Company believes its cancer detection and progression measurement capabilities provide unprecedented monitoring and objective measurement of therapeutic research and results. The Company's focus on cancer research has been validated and further underscored by recent major clinical publications that both validate ChromoCure's chromosomal (aneuploidy) theory of cancer and establish the company's detection approach as the forefront of both cancer detection and research.
3/19/10 - Market Micro Recap For Week Of 3/15/10
3/12/10 - Market Micro Recap For Week Of 3/8/10
3/5/10 - Market Micro Recap For Week Of 3/1/10
2/26/10 - Market Micro Recap For Week Of 2/22/10
